Jonathan Krinsky, chief market technician at BTIG, joins CNBC's 'The Exchange to discuss his outlook on stocks for 2025, what ...

The S&P 500's rally of 1.8% over just the last two sessions is nice, "but not a game changer yet," according to BTIG's technical guru, Jonathan Krinsky. The chart he provides, below, shows the stock ...

BTIG notes that on January 6, Kratos announced that it has been awarded a five-year Other Transaction Agreement for the MultiService Advanced ...

BTIG reiterated a Buy rating and $295 price target on Carvana (CVNA) after the company amended its Master Purchase and Sale Agreement with Ally ...

Here are four large-cap value stocks that growth and income investors may want to consider now. History suggests they will ...

BTIG Research has recently reduced Vuzix Corp (VUZI) stock to Neutral rating, as announced on November 10, 2023, according to Finviz. Earlier, on December 21, 2021, Dawson James had initiated the ...

BTIG's Krinsky noted that while equity markets in the first half of 2024 were fueled mostly by the surge in mega-cap names ...

H.C. Wainwright has recently initiated Nektar Therapeutics (NKTR) stock to Buy rating, as announced on December 10, 2024, according to Finviz. Earlier, on November 4, 2024, Piper Sandler had initiated ...

McDonald's ( MCD) is paving the way for more value competition in 2025 with its new McValue platform. Bernstein analyst Danilo Gargiulo called its first national value offering since 2018 a ...

BTIG lowered the firm’s price target on Staar Surgical (STAA) to $39 from $49 and keeps a Buy rating on the shares as part of ...

Short seller Hindenburg Research accused Carvana of accounting manipulation and unstable loans. The company denies the ...

Such was the situation with marijuana real estate investment trust (REIT) Innovative Industrial Properties ( IIPR -0.95%) in ...